Experimental basis for antioxidants TA99 series in the treatment of Alzheimer disease

Chinese Journal of Clinical Rehabilitation

Volumn 9, Issue 13, 2005, Pages 254-256

  Wang, Hua Qiao ^a   Fan, Hai Hong ^a   Xu, Jie ^a   Li, Guang Wu ^b   Yuan, Qun Fang ^a   Xie, Yao ^a   Yao, Zhi Bin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; ANTIOXIDANT; FREE RADICAL; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; TA 9901; TA 9902; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; APOPTOSIS; BRAIN NERVE CELL; CELL CULTURE; CLINICAL PROTOCOL; DISEASE MODEL; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ELECTRON SPIN RESONANCE; FIBROSIS; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LEARNING; MEDLINE; MEMORY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN SYNTHESIS; RANDOMIZATION; REVIEW; TRANSMISSION ELECTRON MICROSCOPY;

EID: 27644586419     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Frolich L, Riederer P. Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidative treatment. Arzneimittelforschung 1995; 45 (3A): 443-6
2. 1-42 aggregation and fibril formation in vitro. Zhongguo Shenjing Kexue Zazhi 2001; 17(Suppl): 243
3. Schreiter Gasser U, Gasser T. A comparison of cholinesterase inhibitors and ginkgo extract in treatment of Alzheimer dementia. Fortschr Med Orig 2001; 119 (3-4): 135-8
4. Yu ZX, Yao ZB. Antioxidant TA9901 inhibits amyloid-β-protein aggregation and fibril formation in vitro. Zhongguo Shenjing Kexue Zazhi 2000; 16(3): 215-8
5. Yu ZX, Yao ZB. Effect of antioxidant on secondary conformational transition of aged amyloid-β-peptidel -40 by FT-IR quantitative study. Zhongguo Bingli Shenglixue Zazhi 2000; 16(6): 540-4
6. Yu ZX, Wang HQ, Yao ZB, et al. Effect of antioxidant on the fibril formation of Aβ1-40 injected into cerebral cortex of rat brain. Zhongguo Bingli Shenglixue Zazhi 2001; 17(12): 1220-3
7. Yu ZX, Wang HQ, Yuan QF, et al. Inhibitory effect of antioxidant TA9901 on the amyloid granules of senescence-accelerated mouse (SAM-P/8) brain. Jiepou Xuebao 2002; 33(1): 33-7
8. Yu ZX, Wang HQ, Yao ZB. The influence of antioxidants TA9901 on the behavior senescence-accelerated mouse (SAM-P/8). Jiepouxue Yanjiu 2000; 22(2): 45-7
9. Wang HQ, Yu ZX, Li GW, et al. Inhibitory effects of a natural antioxidant TA9901 on amyolid-β-protein (1-40) prptidyl free radical generation. Tianran Chanwu Kaifa yu Yanjiu 2002; 14(3): 58-62
10. Li GW, Wang HQ, Yao ZB. Mechanism of new medicine on Alzheimer's disease: TA9902 on Aβ1-42 by FT-IR. Jiepouxue Yanjiu 2001; 24(1): 71
11. Li GW, Wang HQ, Yao ZB. Antioxidant Egb761 matched TA9901 changes secondary conformation of amyloid-β-peptidel -42 by circular dichroism spectrum. Jiepouxue Yanjiu 2002; 24(2): 135-7
12. Wang HQ, Xie Y, Yao ZB, et al. Premary study of TA9902 on the primary cultured cerebral cortical neurons. Jiepouxue Yanjiu 2001; 23(3): 231
13. Wang HQ, Yuan QF, Xie Y, et al. Effects of TA9902 on amyloid β protein induced neurotoxicity of the primary cultured cerebral cortical neurons. Jiepouxue Zazhi 2004; 27(Supplement): 101
14. Wang HQ, Yuan QF, Yao ZB. Effect of TA9902 on the AchE (acetylcholinesterase) -positive neurofibers in senescence-accelerated mouse. Jiepouxue Yanjiu 2001; 24(1): 71
15. Wang HQ, Yuan QF, Xie Y, et al. Effect of TA9902 on the deposition of amyloid-β-like granules in senescence-accelerated mouse (SAM-P/8) brain. Zhongsan Daxue Xuebao (Yixue Kexueban) 2003; 24(3): 206-10
16. Wang HQ, Yuan QF, Xie Y, et al. Effect of TA9902 on choline acetyltransferase neuron in senescence-accelerated mouse. Jiepou Kexue Jinzhan 2003; 9(2): 113-9
17. Wang HQ, Yao ZB. Effect of TA9902 on the morphological adaptive of synaptic structure in the molecular layer of the dentate gyrus of SAM-P/8 mice. Jiepouxue Yanjiu 2003; 25(2): 166